About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Sumitomo Pharma Co., Ltd.(4506) Summary

4506
TSE Prime
Sumitomo Pharma Co., Ltd.
572
JPY
-7
(-1.21%)
Dec 23, 3:03 pm JST
3.65
USD
Dec 23, 1:01 am EST
Result
PTS
outside of trading hours
572.2
Dec 23, 3:03 pm JST
Summary Chart Historical News Financial Result
PER
PBR
1.99
Yield
ー%
Margin Trading Ratio
4.82
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
579 JPY 3.69 USD
Previous Close Dec 20
579 JPY 3.69 USD
High Dec 23, 9:00 am
581 JPY 3.71 USD
Low Dec 23, 9:27 am
568 JPY 3.62 USD
Volume
1,059,100
Trading Value
0.61B JPY 3.87M USD
VWAP
573.67 JPY 3.66 USD
Minimum Trading Value
57,200 JPY 365 USD
Market Cap
0.23T JPY 1.46B USD
Number of Trades
1,003
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
High
1-Year Average
1,982
1-Year High Oct 30, 2024
10,502
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 574,600 3,441,800 5.99
Dec 6, 2024 638,600 3,669,300 5.75
Nov 29, 2024 570,700 3,788,600 6.64
Nov 22, 2024 675,200 3,257,300 4.82
Nov 15, 2024 602,700 3,476,400 5.77
Company Profile
Sumitomo Pharma Co., Ltd. is a mid-sized pharmaceutical company originating from the Sumitomo Chemical group. The company focuses on developing drugs in the areas of psychiatry and neurology, oncology, and regenerative medicine.
Sector
Pharmaceuticals